Active	Status	Sponsor type	Region	Phase	Filter
10 Active 8 Inactive 18 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

10 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Jeng, Chii
NCT05809765: Effect of Triflow Breathing Training	Completed	N/A	63	RoW	8-week breath training program	Taipei Medical University WanFang Hospital	Hemodialysis Complication, Haemolyses and Related Conditions	05/21	05/21
NCT05079958: Effects of Cognitive-behavioral Education and Exercise Interventions on Smoking Cessation	Recruiting	N/A	172	RoW	cognitive-behavioral education, 12-week brisk walking	Cathay General Hospital	Coronary Artery Disease, Smoking Cessation	12/22	12/22
Sue, Yuh-Mou
TRACK, NCT03969953 / 2020-000334-17: Treatment of Cardiovascular Disease With Low Dose Rivaroxaban in Advanced Chronic Kidney Disease Jan 2025 - Dec 2025: From TRACK trial for cardiovascular disease in chronic kidney disease	Recruiting	3	2000	Europe, Canada, RoW	Rivaroxaban 2.5 Mg Oral Tablet, Xarelto, Placebo	The George Institute, George Clinical Pty Ltd, Bayer, Centre Hospitalier Régional Universitaire de Nancy, King Abdullah International Medical Research Center	Chronic Kidney Diseases, Dialysis-dependent Kidney Failure, Cardiovascular Disease	06/27	12/27
REGEN-006, NCT05099770: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease	Recruiting	3	685	Europe, Canada, US, RoW	Renal Autologous Cell Therapy (REACT), Sham Comparator	Prokidney, Iqvia Pty Ltd, PPD	Type 2 Diabetes Mellitus, Chronic Kidney Diseases	02/27	02/27
Lu, Mong-Liang
NCT06326840: Clinical Efficacy and Adverse Reactions of Antipsychotic Treatment	Completed	N/A	42	RoW	Metformin	Taipei Medical University Hospital, Taipei Medical University	Metabolic Disturbance, Hyperprolactinemia, Schizophrenia	06/11	06/11
Chang
WU-KONG1, NCT03974022: Assessing an Oral EGFR Inhibitor, Sunvozertinib in Patients Who Have Advanced Non-small Cell Lung Cancer with EGFR or HER2 Mutation	Active, not recruiting	1/2	315	Europe, Canada, Japan, US, RoW	Sunvozertinib, DZD9008	Dizal Pharmaceuticals	Non-Small Cell Lung Cancer	07/24	07/25
NCT04516421: Protein Supplementation Intervention for Improving Muscle Mass and Physical Performance in Older People With Sarcopenia	Active, not recruiting	N/A	80	RoW	Protein supplementation, Placebo oat drink	Asia University	Sarcopenia	06/21	06/22
TRUST, NCT03477968: ThRombosis ExclUsion STudy	Terminated	N/A	5935	Europe, US	DDimer test	Diagnostica Stago	Deep Venous Thromboses, Pulmonary Embolism, Venous Thromboembolism	03/23	09/24
NCT06666790: DermaSensor Postmarket Surveillance Study	Recruiting	N/A	396	US	Scan with elastic scattering spectroscopy device to assess risk of malignancy	DermaSensor, Inc.	Melanoma, Skin	04/27	09/27
Chen, Kee-Hsin
NCT05623475: Effects of Scenario-based Education Initiative and OSCE for Recognition and Management of Delirium	Completed	N/A	100	RoW	OSCEs, Lecture, E-learning	Taipei Medical University	Delirium	02/23	02/23